FindTrial
Sign In

Establish a prognostic and curative effect prediction system for triple negative breast cancer using multimodal method

Establish a prognostic and curative effect prediction system for triple negative breast cancer using multimodal method

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800020181
Enrollment
Unknown
Registered
2018-12-19
Start date
2018-12-19
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Patients with poor prognosis and good prognosis:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria of the group with poor prognosis were TNBC with no more than 60 years of age, standard treatment and supporting samples. The patients in the good prognosis group were included in the matching ratio of 1:4, and the matching factors included treatment regimen, age, menopause and clinical stage

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

MeasureTime frame
multi-omics;—

Countries

China

Contacts

Public ContactHong Zheng
hzheng@scu.edu.cn18980601830

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026